This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
No retransfusion of cardiotomy blood via heart- and lung mashine
University Hospital in Örebro
Örebro, Sweden
blood loss
Hemoglobin
Time frame: During 5 days hemoglobin will be measured as the clinical rutine or as needed.
Blood loss
Blood volume in millilitre (mL)
Time frame: During 2 days or while surgical drains remains, blood volume in mL is measured.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.